Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Leases (2019 - 2025)

Historic Leases for UroGen Pharma (URGN) over the last 7 years, with Q3 2025 value amounting to $5.4 million.

  • UroGen Pharma's Leases rose 41245.25% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 41245.25%. This contributed to the annual value of $2.3 million for FY2024, which is 3674.45% up from last year.
  • As of Q3 2025, UroGen Pharma's Leases stood at $5.4 million, which was up 41245.25% from $4.3 million recorded in Q2 2025.
  • UroGen Pharma's 5-year Leases high stood at $5.4 million for Q3 2025, and its period low was $945000.0 during Q1 2022.
  • In the last 5 years, UroGen Pharma's Leases had a median value of $1.9 million in 2023 and averaged $2.2 million.
  • As far as peak fluctuations go, UroGen Pharma's Leases crashed by 6562.77% in 2021, and later surged by 41245.25% in 2025.
  • Over the past 5 years, UroGen Pharma's Leases (Quarter) stood at $1.2 million in 2021, then skyrocketed by 107.8% to $2.5 million in 2022, then tumbled by 31.85% to $1.7 million in 2023, then surged by 36.74% to $2.3 million in 2024, then soared by 135.93% to $5.4 million in 2025.
  • Its Leases stands at $5.4 million for Q3 2025, versus $4.3 million for Q2 2025 and $4.1 million for Q1 2025.